Virtual Biosecurity Center | Your online source for biosecurity news, events, reports and other information.

Op-Ed – Dual-Use Research: Is it possible to protect the public without encroaching rights?

T. Tosin Fadeyi, Master’s Candidate, Biotechnology (Biodefense and Biosecurity Concentration), University of Maryland University College For decades, scientists have had reasonable freedom and control over their research and experiments and able to publish and share their work without much inconvenience. The freedom of creativity in the field of science is much like that of an artist – often fueled by an inspiration from other sources, a passion for a unique realm of art (in this case, science), and a natural curiosity. Within reasonable limits, artists and scientists had the world at their fingertips; as long as they weren’t causing a societal disruption Read More »
- May 18, 2015 |
- Filed Under Biosafety, Biotechnology, International, Policy & Initiatives, Research
Book Review: Bioinsecurity and Vulnerability

Reviewed by T. Tosin Fadeyi Edited by Nancy N. Chen and Lesley A. Sharp Contributors: Steven C. Caton, Nancy N. Chen, Joseph Masco, Monir Moniruzzaman, Carolyn Rouse, Lesley A. Sharp, Glenn Davis Stone, Ida Susser, David Vine, and Michael J. Watts. Bioinsecurity and Vulnerability is an intuitive compilation of writings that explore the hysteria surrounding preparation for a silent threat: biological terror. The essays in this book illustrate the reality of biological preparedness in the 21st century by bringing together previously unacquainted realms like genetic engineering, the military, and accidental disasters around the world. Bioinsecurity features relevant photography to illustrate and enhance the contributors’ discussions. Rather Read More »
- April 30, 2015 |
- Filed Under Biosafety, Bioterrorism, International, Policy & Initiatives
Op-Ed – Microbial Forensic Attribution: Where Science Meets International Relations

Christopher A. Bidwell, JD, Senior Fellow for Nonproliferation Law and Policy, Federation of American Scientists & Mark Jansson, Program Manager, CRDF Global. The U.S. government is making significant investments in bio forensics as a tool for attribution. In order for that investment to pay-off, it must be combined with investments in international collaborations so that the science behind any future attribution claims that may be made are accepted as fact, both in scientific and political terms. To better understand how evidence derived from microbial forensics will be received in international contexts among people with different cultural, professional, and political backgrounds, the Federation of American Read More »
- July 17, 2014 |
- Filed Under Agents & Toxins, Biocrimes, Biological Weapons, Biosafety, Bioterrorism, Countermeasures, International, Policy & Initiatives, Public Health
Op-Ed – Science Needs for Microbial Forensics: Developing Initial International Research Priorities

Committee on Science Needs Microbial Forensics: Developing an Initial International Roadmap, Board on Life Sciences, Division of Earth and Life Sciences, National Research Council of the National Academies. Today we find ourselves with a complex infrastructure of government agencies, Select Agent registries, regulated research, environmental monitoring in designated cities, federal and state regulations—all resulting from one more or less successful biological attack on the United States. The Amerithrax attack with highly refined material produced by a knowledgeable expert (presumably in a U.S. bioweapons laboratory) resulted in 22 illnesses and 5 deaths. Approximately 4 g of material were used in the Amerithrax attack. Read More »
- July 17, 2014 |
- Filed Under Agents & Toxins, Agriculture, Biocrimes, Biological Weapons, Biosafety, Biotechnology, Bioterrorism, Countermeasures, International, Policy & Initiatives, Public Health, Research
Vaccinations have prevented at least 103 million cases of contagious disease since 1924

(TheVerge) Vaccinations have been credited with some of humanity’s greatest health technological triumphs over disease, including drastically reducing polio around the globe and almost eliminating smallpox entirely. But how many people have been spared life-threatening infections thanks to the introduction of vaccines? At least 103.1 million children in the US alone since 1924, according to a new analysis of historical infection rate data going back to 1888.
- December 2, 2013 |
- Filed Under Policy & Initiatives, Public Health

Browse by region

Browse By Category

Researchers advance fight against leading infectious cause of congenital birth defects

(EurekAlert) A virus most people probably have never heard of, but that the majority of us carry, is the No. 1 infectious cause of congenital birth defects in the U.S. today. Because of cytomegalovirus (CMV) infection during in utero development, 1 in 750 children are born with or develop permanent disabilities Read More »

March 14, 2013
| Filed under North America and Research
Share

The Deadly Virus That’s Spreading Faster Than Malaria or West Nile

(TakePart) About half of the world is at risk of a virus that Americans don’t know at all. For Americans, dengue fever is about as foreign as the metric system or the leading contenders in next year’s World Cup. But while we don’t know much about it, for the rest of Read More »

March 14, 2013
| Filed under North America and Public Health
Share

Aeolus Provides Investor Update on Passage of Pandemic All-Hazards Preparedness Act of 2013

(Marketwire) Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS), a biotechnology company leveraging significant government funding to develop a platform of novel compounds to protect against radiological and chemical threats and for use in oncology, provided an update to investors on the Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (PAHPRA). The bill was Read More »

March 14, 2013
| Filed under North America, Biotechnology, and Policy & Initiatives
Share

Aeolus Provides Investor Update on Passage of Pandemic All-Hazards Preparedness Act of 2013

MISSION VIEJO, CA–(Marketwire – Mar 14, 2013) – Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS)

March 14, 2013
| Filed under Biotechnology
Share

Obama Signs Pandemics and All-Hazards Preparedness Act of 2013

The Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA) of 2013 was signed into law yesterday by President Barack Obama. The legislation reauthorizes provisions of the Project Bioshield Act of 2004 and the Pandemic and All-Hazards Preparedness Act (PAHPA) of 2006 … Continue reading →

March 14, 2013
| Filed under Policy & Initiatives and Public Health
Share

« First «...10 20 30...247 248249250 251...260 270 280...»Last »

Upcoming Events More »
There are no upcoming events at this time.
Global Forum on BIORISK

SIGN IN | REGISTER
Recent Blog Posts More »
- Op-Ed – Dual-Use Research: Is it possible to protect the public without encroaching rights?
  
  T. Tosin Fadeyi, Master’s Candidate, Biotechnology (Biodefense and Biosecurity Concentration), University of Maryland Read More »
- Book Review: Bioinsecurity and Vulnerability
  
  Reviewed by T. Tosin Fadeyi Edited by Nancy N. Chen and Lesley A. Read More »
- Op-Ed – Microbial Forensic Attribution: Where Science Meets International Relations
  
  Christopher A. Bidwell, JD, Senior Fellow for Nonproliferation Law and Policy, Federation of American Read More »
- Op-Ed – Science Needs for Microbial Forensics: Developing Initial International Research Priorities
  
  Committee on Science Needs Microbial Forensics: Developing an Initial International Roadmap, Board on Read More »
- Op-Ed – A Necessary Biopreparedness Priority: Strengthening the Medical Countermeasures Enterprise
  
  Christina England, Master’s Candidate, Security Policy, University of Maryland School of Public Policy; Read More »

BAA – Medical Countermeasures for Priority Pathogens

(Global Biodefense) The National Institute of Allergy and Infectious Diseases (NIAID) has released Read More »
New Antibody Weapons Against Marburg Virus

(Global Biodefense) A new study led by scientists at The Scripps Research Institute identifies Read More »
FDA Accepts BLA for Inhalational Anthrax Countermeasure

(Global Biodefense) Anthim (obiltoxaximab) is for the treatment and prevention of inhalational anthrax, Read More »
South Korea MERS death toll rises to 20

(CNN) The World Health Organization said Tuesday that the number of new cases Read More »
What you should know about MERS, the mystery disease that has South Korea on edge

(Washington Post) The spread of MERS, which has infected 126 people since the outbreak began last Read More »